AbTis is Biotechnology in South Korea that focus on novel antibodies business. Founded in 2016. They cover business area such as operator, antibody-drug conjugation technology, solubilization, efficacy, commercial antibody, novel antibody, development, no mutation, engineering, medical professional, access, antibody-drugconjugate.
2016
( 8 years old in 2024 )
Novel Antibodies
-
Venture Valley 2 A-815
Sanup-ro 156, 142-10 Kwonsun-gu
Suwon-si, Gyeonggi-do 16648
South Korea
Private
operatorantibody-drug conjugation technologysolubilizationefficacycommercial antibodynovel antibodydevelopmentno mutationengineeringmedical professionalaccessantibody-drugconjugate
* We use standard office opening hours in near AbTis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AbTis is Biotechnology business from South Korea that founded in 2016 (8 years old in 2024), AbTis business is focusing on Novel Antibodies.
AbTis headquarter office and corporate office address is located in Venture Valley 2 A-815 Sanup-ro 156, 142-10 Kwonsun-gu Suwon-si, Gyeonggi-do 16648 South Korea.
AbTis was founded in South Korea.
In 2024, AbTis is currently focus on novel antibodies sector.
Above is snippet of Google Trends for "novel antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AbTis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
